PT  - JOURNAL ARTICLE
AU  - Nicolò Bizzarri
AU  - Zoia Razumova
AU  - Ilker Selcuk
AU  - Nadja Taumberger
AU  - Tanja Nikolova
AU  - Christina Fotopoulou
AU  - Elzbieta Van der Steen-Banasik
AU  - Annamaria Ferrero
AU  - Kamil Zalewski
TI  - Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019)
AID  - 10.1136/ijgc-2020-001226
DP  - 2020 Mar 05
TA  - International Journal of Gynecologic Cancer
PG  - ijgc-2020-001226
4099  - http://ijgc.bmj.com/content/early/2020/03/05/ijgc-2020-001226.short
4100  - http://ijgc.bmj.com/content/early/2020/03/05/ijgc-2020-001226.full
AB  - This is a report from the 21st Meeting of the European Society of Gynaecological Oncology (ESGO 2019) held in Athens, Greece, November 2–5, 2019. The conference offered state of the art educational sessions, and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also on emerging trends. Current innovations in gynecological cancers were also discussed. The new rare tumor guidelines project, a joint initiative with the ESGO-Gynecologic Cancer InterGroup, was officially presented for the first time. Moreover, other developments achieved with other societies, such as the European Society for Medical Oncology for ovarian cancer, the European Federation for Colposcopy for cervical cancer prevention and screening, and the European Society for Pediatric Oncology for gynecologic cancers in adolescents, were presented. Here we highlight the key results of the latest gynecological cancer trials that were presented for the first time at ESGO 2019 and added great value to this prestigious scientific congress.